$ATIP
ATI Physical Therapy, Inc.

2020 Q2 Form 10-K Financial Statement

#000181584921000004 Filed on March 09, 2021

View on sec.gov

Income Statement

Concept 2020 Q2
Revenue $107.8M
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $24.79M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.718M
YoY Change
% of Gross Profit
Operating Expenses $24.79M
YoY Change
Operating Profit -$13.65M
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $44.10M
YoY Change
Pretax Income -$15.62K
YoY Change
Income Tax $3.600M
% Of Pretax Income
Net Earnings $2.741M
YoY Change
Net Earnings / Revenue 2.54%
Basic Earnings Per Share $0.02
Diluted Earnings Per Share $0.02
COMMON SHARES
Basic Shares Outstanding 128.3M shares
Diluted Shares Outstanding 128.3M shares

Balance Sheet

Concept 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.00K
YoY Change
Cash & Equivalents $142.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $25.00K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $84.27K
YoY Change
Total Long-Term Assets $84.27K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $25.00K
Total Long-Term Assets $84.27K
Total Assets $109.3K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $99.89K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $99.89K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $99.89K
Total Long-Term Liabilities $0.00
Total Liabilities $99.89K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$15.62K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $0.00
YoY Change
Total Liabilities & Shareholders Equity $109.3K
YoY Change

Cashflow Statement

Concept 2020 Q2
OPERATING ACTIVITIES
Net Income $2.741M
YoY Change
Depreciation, Depletion And Amortization $9.718M
YoY Change
Cash From Operating Activities $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $25.00K
YoY Change
NET CHANGE
Cash From Operating Activities $0.00
Cash From Investing Activities
Cash From Financing Activities $25.00K
Net Change In Cash $25.00K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 faii Investment Securities Maturity Period
InvestmentSecuritiesMaturityPeriod
P185D
dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
dei Entity Central Index Key
EntityCentralIndexKey
0001815849
CY2020Q3 faii Number Of Redeemable Warrants In Each Unit Issued In Public Offering
NumberOfRedeemableWarrantsInEachUnitIssuedInPublicOffering
0.2 shares
dei Document Type
DocumentType
10-K
dei Document Annual Report
DocumentAnnualReport
true
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39439
dei Entity Registrant Name
EntityRegistrantName
FORTRESS VALUE ACQUISITION CORP. II
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1408039
dei Entity Address Address Line1
EntityAddressAddressLine1
1345 Avenue of the Americas
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10105
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-345000000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 USD
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
798-6100
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
dei Entity Shell Company
EntityShellCompany
true
CY2020Q4 dei Entity Public Float
EntityPublicFloat
366904893 USD
CY2020Q4 us-gaap Cash
Cash
1313454 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
345938 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1659392 USD
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
345018957 USD
CY2020Q4 us-gaap Assets
Assets
346678349 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1573061 USD
CY2020Q4 faii Franchise Tax Payable Current
FranchiseTaxPayableCurrent
112022 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1685083 USD
CY2020Q4 faii Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
12075000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
13760083 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6587611 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1588639 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000006 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
346678349 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1495574 USD
faii Franchise Tax Expense
FranchiseTaxExpense
112022 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1607596 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
18957 USD
us-gaap Net Income Loss
NetIncomeLoss
-1588639 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
0 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 USD
faii Sale Of Units In Initial Public Offering Net Of Offering Costs Par Value
SaleOfUnitsInInitialPublicOfferingNetOfOfferingCostsParValue
325581905 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
8900000 USD
faii Reclassifications Of Permanent To Temporary Equity
ReclassificationsOfPermanentToTemporaryEquity
-327918260 USD
us-gaap Net Income Loss
NetIncomeLoss
-1588639 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000006 USD
us-gaap Net Income Loss
NetIncomeLoss
-1588639 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
18957 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
345938 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1284393 USD
faii Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
112022 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-557119 USD
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
345000000 USD
CY2020Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
345000000.0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
97250 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
97250 USD
faii Proceeds From Issuance Initial Public Offering Net Of Underwriting Commission
ProceedsFromIssuanceInitialPublicOfferingNetOfUnderwritingCommission
338100000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
154427 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8900000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
346870573 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1313454 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1313454 USD
faii Offering Costs Accounts Payable And Accrued Expenses Noncash
OfferingCostsAccountsPayableAndAccruedExpensesNoncash
288668 USD
faii Deferred Offering Costs Noncash Financing Activities
DeferredOfferingCostsNoncashFinancingActivities
12075000 USD
us-gaap Stock Issued1
StockIssued1
327918260 USD
CY2020Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
19400000 USD
CY2020Q3 faii Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
12100000 USD
CY2020Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8900000 USD
CY2020Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
345000000.0 USD
CY2020Q4 us-gaap Cash
Cash
1300000 USD
CY2020Q4 faii Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance
MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
0.80
CY2020Q4 faii Minimum Percentage Of Voting Interests To Be Acquired In Business Combination
MinimumPercentageOfVotingInterestsToBeAcquiredInBusinessCombination
0.50
CY2020Q4 faii Minimum Net Tangible Assets To Complete Business Combination
MinimumNetTangibleAssetsToCompleteBusinessCombination
5000001 USD
CY2020Q4 faii Minimum Net Tangible Assets To Complete Business Combination
MinimumNetTangibleAssetsToCompleteBusinessCombination
5000001 USD
CY2020Q4 faii Percentage Of Public Shares Required To Repurchase If Business Combination Is Not Completed Within Specific Period
PercentageOfPublicSharesRequiredToRepurchaseIfBusinessCombinationIsNotCompletedWithinSpecificPeriod
1
faii Number Of Fractional Warrants Be Issued
NumberOfFractionalWarrantsBeIssued
0 shares
CY2020Q4 us-gaap Cash
Cash
1300000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
18957 USD
CY2020Q4 faii Working Capital Deficit
WorkingCapitalDeficit
26000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed as of December 31, 2020, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div>
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
345000000.0 USD
CY2020Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
19400000 USD
CY2020Q3 faii Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
12100000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
18957 USD
faii Investment Income Interest Income Used To Pay Taxes
InvestmentIncomeInterestIncomeUsedToPayTaxes
18957 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which at times may exceed the Federal depository insurance coverage of $250,000. As of December 31, 2020, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
CY2020Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2020Q3 faii Number Of Shares In Each Unit
NumberOfSharesInEachUnit
1 shares
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 USD
faii Common Stock Threshold Trading Days
CommonStockThresholdTradingDays
20 day
faii Common Stock Threshold Consecutive Trading Days
CommonStockThresholdConsecutiveTradingDays
30 day
faii Class Of Warrant Or Right Blackout Trading Period After Completion Of Business Combination
ClassOfWarrantOrRightBlackoutTradingPeriodAfterCompletionOfBusinessCombination
P30D
CY2020Q3 faii Underwriting Agreement Option Period
UnderwritingAgreementOptionPeriod
P45D
CY2020Q3 faii Underwriting Discount
UnderwritingDiscount
0.20
CY2020Q3 faii Underwriting Discount Paid
UnderwritingDiscountPaid
6900000 USD
CY2020Q3 faii Deferred Underwriting Discount
DeferredUnderwritingDiscount
0.35
CY2020Q3 faii Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
12100000 USD
CY2020Q4 faii Class F Percentageof Total Common Stock Outstanding Upon Completionof Initial Public Offering
ClassFPercentageofTotalCommonStockOutstandingUponCompletionofInitialPublicOffering
0.20
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
faii Warrants Exercise Period Following Business Combination
WarrantsExercisePeriodFollowingBusinessCombination
P30D
faii Warrants Exercise Period Following Initial Public Offering
WarrantsExercisePeriodFollowingInitialPublicOffering
P12M
CY2020Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
faii Restriction Period For Transfer Assignment Or Sale
RestrictionPeriodForTransferAssignmentOrSale
P30D
faii Redemption Price Per Warrant
RedemptionPricePerWarrant
0.01
faii Numberof Daysfor Written Noticeof Redemption
NumberofDaysforWrittenNoticeofRedemption
P30D
faii Minimum Threshold Priceof Common Stock Specifiedto Send Noticeof Redemptiontothe Warrant Holders
MinimumThresholdPriceofCommonStockSpecifiedtoSendNoticeofRedemptiontotheWarrantHolders
18.00
faii Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price
PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice
9.20
CY2020Q4 faii Percentageof Warrant Exercise Price Adjustedto Price Receivedin New Issuance
PercentageofWarrantExercisePriceAdjustedtoPriceReceivedinNewIssuance
1.15
CY2020Q4 faii Deferred Tax Assets Organizational Costs And Net Operating Loss
DeferredTaxAssetsOrganizationalCostsAndNetOperatingLoss
333614 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
333614 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
333614 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-333614 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-333614 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
93065 USD
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-333614 USD
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.210
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000

Files In Submission

Name View Source Status
0001815849-21-000004-index-headers.html Edgar Link pending
0001815849-21-000004-index.html Edgar Link pending
0001815849-21-000004.txt Edgar Link pending
0001815849-21-000004-xbrl.zip Edgar Link pending
exhibit311-10xkxfortressva.htm Edgar Link pending
exhibit312-10xkxfortressva.htm Edgar Link pending
exhibit321-10xkxfortressva.htm Edgar Link pending
exhibit322-10xkxfortressva.htm Edgar Link pending
faii-20201231.htm Edgar Link pending
faii-20201231.xsd Edgar Link pending
faii-20201231_cal.xml Edgar Link unprocessable
faii-20201231_def.xml Edgar Link unprocessable
faii-20201231_htm.xml Edgar Link completed
faii-20201231_lab.xml Edgar Link unprocessable
faii-20201231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending